Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,397.00
-3.00 (-0.21%)
At close: Feb 27, 2026

Kwangdong Healthbio Market Cap

Kwangdong Healthbio has a market cap or net worth of 17.72 billion as of February 27, 2026. Its market cap has increased by 6.09% in one year.

Market Cap
17.72B
Enterprise Value
n/a
Revenue
38.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,397.00

Market Cap Chart

Since April 5, 2017, Kwangdong Healthbio's market cap has decreased from 20.68B to 17.72B, a decrease of -14.27%. That is a compound annual growth rate of -1.71%.

History

DateMarket Cap% Change
Feb 27, 202617.72B-11.25%
Dec 30, 202519.97B14.12%
Dec 30, 202417.50B-38.70%
Dec 28, 202328.55B23.01%
Dec 29, 202223.21B-12.02%
Dec 30, 202126.38B-4.04%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Union Korea Pharm 19.70B
WooGene B&G 21.93B
CXI Healthcare Technology Group 13.77B
BIFIDO 24.46B
Future Medicine 12.80B
Bioten 11.79B
Daesung Microbiological Labs. 26.75B
Pharmsville 27.82B
Market Cap Rankings